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Antioxidant promotion of tyrosine nitration in the
presence of copper(II)†
Liang Qiao,a Baohong Liub and Hubert H. Girault*a
Copper(II) is known to catalyze the generation of reactive nitrogen species in the presence of hydrogen
peroxide, nitrite or nitric oxide, leading to tyrosine nitration, a biomarker for free radical species
associated diseases. Here, we find that biological antioxidants such as ascorbic acid can promote
tyrosine nitration in the presence of copper(II) and nitrite under aerobic and weak acidic conditions.
Tyrosine nitration is demonstrated on both the b-amyloid peptide and angiotensin I. These studies show
that (i) ascorbic acid works as a pro-oxidant in the presence of copper(II) to induce oxidation and
nitration on peptides, (ii) both free and coordinated copper(II) can catalyze peptide oxidation and
nitration, (iii) nitration occurs under mild acidic conditions (pH = 6.0–6.5).
Introduction
Tyrosine nitration has been demonstrated as a biomarker for
free radical species associated diseases, such as cardiovascular
diseases,1 Alzheimer’s disease2–4 and Parkinson’s disease.5 It is
important to study the pathways and mechanisms of tyrosine
nitration for an in-depth understanding of these pathologies.
Two reactive nitrogen species, peroxynitrite anions (ONOO)
and nitrogen dioxide radicals (NO2), are considered to directly
react with the tyrosine residues resulting in their nitration.6,7
ONOO is generated in vivo by the very fast reaction between
nitric oxide (NO) and the superoxide anion (O2
).8–10 Alterna-
tively, enzyme–ONOO complexes can be generated from the
reaction of peroxidases with hydrogen peroxide (H2O2) and
nitrite (NO2
).11 Different pathways lead to the production of
NO2 both in vitro and in vivo, including the oxidation of nitric
oxide (NO) by oxygen,12 the decomposition of ONOO6,10,13
and the oxidation of nitrite (NO2
) by hydrogen peroxide (H2O2)
catalyzed by peroxidases14 or other species having similar
peroxidase properties, such as superoxide dismutase (SOD)15–18
and Hemin-containing proteins.19
Recently, we have demonstrated that copper(II) and coordi-
nated copper(II) are also able to catalyze the generation of NO2
from nitrite and H2O2.
20 A key complex of copper(II)–hydroperoxo
can be generated from copper(II) and the hydroperoxide anion
(HO2
), and further decomposed to form copper(I), which is
able to react with H2O2 to produce hydroxyl radicals (OH) via
Fenton-reactions. The radicals can be scavenged by NO2
 to
form NO2. In the presence of tyrosine, tyrosine radicals (Tyr)
are also formed, leading to tyrosine nitration.
In vivo, copper(II) is the major source of reactive oxygen
species (ROS) via Fenton Haber Weiss reactions. Interest in
Alzheimer’s disease has led to intensive studies on the genera-
tion of ROS catalyzed by copper(II) with or without the presence
of b-amyloid (Ab) peptides and biological antioxidants, such as
ascorbic acid.21 To date, many conflicting studies have been
reported. Ab peptides have been suggested to act either as
antioxidants to scavenge ROS22 or as pro-oxidants to promote
the generation of ROS.23 Hureau et al. have reviewed compre-
hensively the Ab mediated ROS production in the presence
of copper ions.24 In vivo, the concentration of copper(II) ions
can be 15–20 mM in plasma, B250 nM in cerebrospinal fluid
(CSF) and as high as 250 mM when they are released at the
synapse.25,26 The concentration of copper ions in the brain
increases with age. In Alzheimer’s disease, the concentration of
copper was found in cerebral amyloid deposits at an abnormally
high concentration of 340 mM.27 Copper is also reported to
bind strongly with Ab peptides, where the binding happens
mainly on the N-terminal part of the peptides, especially
histidine residues (His13-His14).28–31 All in all, the literature
suggests an important role of copper in aging, especially
Alzheimer’s disease. On the other hand, the literature also
suggests tyrosine nitration as a biomarker in Alzheimer’s
disease.2–4 Therefore, the performance of copper(II) in tyrosine
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nitration under oxidative and nitrative stresses is of significant
interest.
Herein, we have studied the tyrosine nitration catalyzed by
copper(II) in the presence of nitrite, ascorbic acid and Ab
peptides under aerobic conditions. The reaction was performed
in vitro under mildly basic (pH = 8.0), neutral and mildly acidic
conditions (pH = 6.0, 6.5) at 37 1C or 25 1C. Both oxidation and
nitration products were observed by electrospray ionization
mass spectrometry (ESI-MS) and tandem mass spectrometry
(MS/MS) for the validation of nitration and oxidation sites on
peptides. It was found that reactive oxygen species H2O2 and
OH were generated by the reduction of oxygen by ascorbic acid
under the catalysis of copper(II). The ROS could be further
scavenged by nitrite to induce the generation of NO2 for
tyrosine nitration. The nitration was demonstrated on both b
amyloid peptide and angiotensin I with free cupric ions or
coordinated cupric ions. The concentrations of copper(II) used
to catalyze the reactions ranged from 25 mM to 5 mM, which
covered the reported physiological copper(II) concentration in
plasma, synapse and cerebral amyloid deposits.25–27 Reactant
concentrations and reaction conditions were varied for mecha-
nism study. The current work can be important for the study of
tyrosine nitration and copper(II) toxicity for neurodegenerative
diseases.
Experimental
Chemicals and materials
Angiotensin I (H2N–DRVYIHPFHL–COOH, 98%) and b-amyloid
peptide 1–16 (Ab16 H2N–DAEFRHDSGYEVHHQK–COOH) were
purchased from Bachem (Switzerland). Acetic acid (99.8%) was
purchased from Merck. Copper(II) chloride (CuCl22H2O, 99%)
was bought from Acros. Sodium nitrite (NaNO2, 99%) and
ammonium bicarbonate (NH4HCO3, Z99.5%) were purchased
from Fluka. Methanol (HPLC grade) was purchased from
Applichem. L(+)-Ascorbic acid (99.7%) was bought from Riedel-de
Hae¨n. All these reagents were used as received without further
purification. Deionized water (18.2 MO cm) was obtained from
an ultra-pure water system (Milli-Q 185 Plus, Millipore) and
used for all experiments.
In vitro oxidation and nitration of peptides
The nitration and oxidation of the peptides were performed by
incubating angiotensin I or Ab16 with nitrite, ascorbic acid and
copper(II) chloride in NH4HCO3 aqueous solution at 37 1C or
25 1C and under persistent stirring (500 rpm). NH4HCO3 was
dissolved in water at various concentrations to form buﬀers.
The pH of the solution containing both buﬀer and reactants
was measured using Whatmans Panpehat pH indicator strips
0–14 (Sigma-Aldrich). The reactant concentrations and reaction
time were varied to study the mechanism and kinetics of the
nitration.
In the case of Ab16 peptide bound copper(II) catalyzed
tyrosine nitration, the copper chloride (25 mM) was first
mixed with Ab16 peptide (100 mM) to coordinate all cupric ions
with Ab16. Then, the other reactants were added for the
subsequent oxidation and nitration of peptides.
Mass spectrometry characterization of the reaction products
Reaction products were collected and diluted 10 times in an ESI
buﬀer (1% acetic acid in 50% methanol and 49% water)
followed immediately by the analysis using ESI-MS (Thermo
LTQ Velos). The buﬀer was used to adjust the solution pH to a
low value to form positively charged ions of the modified and
non-modified peptides. Methanol was added to decrease the
solvent surface tension thereby easily initializing the ESI. The
diluted sample was injected into a commercial standard ESI
emitter at a flow rate of 10 ml min1. The ESI was performed at a
high voltage of 3.7 kV and a sheath nitrogen gas flow of 5 psi.
The generated ions were detected using a linear ion trap mass
spectrometer, where the scan rate was 10 000 Th s1 for
enhanced resolution. Mass spectrometer parameters were
kept constant during all experiments for quantitative analysis.
Collision induced dissociation (CID) was used for tandem mass
spectrometry. The fragmentation was performed on selected
parent ions with 20–30 of instrumental collision energy.
Results and discussion
Chemistry background for the tyrosine nitration catalyzed by
copper(II) in the presence of ascorbic acid and nitrite
Although there are many conflicting reports on the perfor-
mance of Ab peptides in the generation of ROS, there is a basic
agreement that copper(II) facilitates the reduction of oxygen to
H2O2 in the presence of biological reductants, e.g. glutathione
and ascorbic acid, via a two-step reaction:32
Cu2+ + Red- Cu+ + Ox
2Cu+ + O2 + 2H
+- 2Cu2+ + H2O2 (1)
where Red is the reductant and Ox is the oxidant. In the case of
ascorbic acid (AA) as a reductant, the first step would be:
2Cu2+ + AA- 2Cu+ + DA + 2H+ (2)
where DA is the dehydroascorbic acid. During the reaction,
copper(II) works as a catalyst for the reduction of oxygen to
hydrogen peroxide by ascorbic acid. However, copper(II) and
copper(I) can further catalyze the decomposition of H2O2
according to our previous study on tyrosine nitration as
follows:20
Cu2+ + H2O2- Cu
2+  (OOH)  H+
Cu2+  (OOH)- Cu+ + O2 + H+ (3)
Cu+ + H2O2- Cu
2+  OH + OH
Such a reaction mechanism has been previously suggested.33
The first two steps in eqn (3) are essentially the Harber–Weiss
cycle, while the last step is the Fenton reaction. According to
previous studies of tyrosine nitration, one of the reactive
nitrogen species that can induce direct nitration on tyrosine
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is nitrogen dioxide (NO2),
20 which can be generated from
nitrite in the presence of hydroxyl radicals:
OH + NO2
- NO2 + OH

OH + Tyr- Tyr + H2O (4)
NO2 + Tyr - NO2-Tyr
where Tyr is tyrosine and NO2-Tyr is nitrated tyrosine. There-
fore, one can expect the nitration of tyrosine in the presence of
copper(II), ascorbic acid, oxygen and nitrite.
Tyrosine nitration on angiotensin I and b
amyloid 1–16 catalyzed by copper(II) ions
Two peptides, angiotensin I (Ang I) and b amyloid 1–16 (Ab16),
were selected as model targets for the nitration on tyrosine.
Angiotensin I is an extracellular peptidic pre-hormone involved
in the physiological procedures that control blood pressure.
This peptide contains one tyrosine residue. We chose Ang I as one
of the targets for tyrosine nitration because of its easy characteri-
zation by mass spectrometry. By incubating angiotensin I with
ascorbic acid, sodium nitrite (NaNO2) and copper(II) in NH4HCO3
buffer (pH = 6) for 18 hours under persistent shaking, nitrated
Ang I (Ang I + NO2, m/z = 448.0 Th, z = 3) and oxidized Ang I
(Ang I + O,m/z = 438.3 Th, z = 3) were generated and detected by
the ESI-MS together with the unmodified Ang I (m/z = 433.0 Th,
z = 3), as shown in Fig. 1(a). The charge state for each ion was
directly obtained from the isotopic peaks thanks to the suffi-
cient MS resolution.
b-Amyloid (Ab) peptides are of great interest in the mecha-
nistic study of Alzheimer’s disease. Ab16 contains one tyrosine
residue and is reported to coordinate copper(II) ions.29 Recent
study shows that the nitration on tyrosine 10 of Ab peptides
accelerates its aggregation and plaque formation, where the
nitration was induced by nitric oxide.34 Replacing Ang I by Ab16
for the copper(II) catalyzed tyrosine nitration, nitrated Ab16
(Ab16 + NO2,m/z = 667.7 Th, z = 3) and oxidized Ab16 (Ab16 + O,
m/z = 658.0 Th, z = 3) were also observed by mass spectrometry
together with unmodified Ab16 (m/z = 652.7 Th, z = 3) as shown
in Fig. 1(b). Diﬀerent concentrations of copper(II) were employed
for inducing Ang I and Ab16 nitration, indicating that copper(II)
either as a trace or in abundant amounts can catalyze peptide
nitration.
The collision induced dissociation (CID) tandem MS techni-
que was used to characterize the structure of nitrated and
oxidized peptides. As shown in Fig. 2(a), the nitrated b4*, b5*,
b6*, b8*, b9*, y7*, y8* and y9* fragments were observed, indicat-
ing that the nitration happened on the 4th amino acid residue
in the sequence, that is, tyrosine. The tandem MS spectrum of
oxidized Ang I gave a more complex pattern: oxidized b6*, b8*,
b9* and b10* fragments were observed while non-oxidized b6, b8,
and a9 were also generated, see Fig. 2(b). This fragmentation
result suggested that either the 6th or the 9th amino acid
residues in the sequence was oxidized, which are both histidine,
and that the parent peak at m/z = 438.3 Th showed a mixture of
the two oxidized products. Fig. 2(c) shows the MS/MS result of
nitrated Ab16 where b-fragments were nitrated from b10* to b15*
and y-fragments were nitrated from y7* to y15*, indicating that
the tyrosine as the 10th amino acid residue in Ab16 was nitrated.
The generation of nitrated or oxidized fragments was demon-
strated by the observation of an increase in the molecular weight
of 45 Da or 16 Da, respectively.
Tyrosine nitration influenced by reactant concentrations
According to previous studies, the intensity ratio of the peaks
on mass spectra of Ang I and Ang I + NO2 is proportional to the
amount ratio of these two peptides in the sample with a slope
at around 1.20 Since tyrosine is an amino acid polar but
uncharged, the nitration on the tyrosine residue of Ang I would
not change the charge states of the peptide, and thus Ang I +
NO2 shows similar eﬃciency in the generation of triple proto-
nated ions as Ang I. In this work, we demonstrated by standard
addition calibration that the peak intensity ratio of Ang I and
Ang I + O is also proportional to their amount ratio but with a
slope at around 8, as is shown in ESI-1.† In Ang I, 3 basic amino
acid residues (e.g. the 2nd amino acid R, the 6th and the 9th
amino acids H) contribute the positive changes of the peptide
in addition to its N-terminal. After oxidation on one histidine,
Fig. 1 (a) Mass spectrum of nitrated (Ang I + NO2) and oxidized angiotensin I
(Ang I + O) generated by incubating angiotensin I (Ang I, 25 mM) with CuCl2
(1 mM), ascorbic acid (AA, 1 mM) and NaNO2 (1 mM) in 1 mM NH4HCO3 (pH = 6)
for 18 hours under persistent shaking; (b) mass spectrum of nitrated (Ab16 + NO2)
and oxidized b-amyloid 1–16 (Ab16 + O) generated by incubating b-amyloid 1–16
(Ab16, 0.1 mM) with CuCl2 (0.025 mM), AA (1 mM) and NaNO2 (1 mM) in 1 mM
NH4HCO3 (pH = 6) for 18 hours under persistent shaking. The reaction was
performed at 37 1C. The products were diluted 10 times in the ESI buffer (49%
water/50% methanol/1% acetic acid) and infused at a flow rate of 10 ml min1
into ESI-MS at an ionization voltage of 3.7 kV. The peaks without label are mainly
attributed to contaminants of the synthesized Ang I and Ab16 and background
contaminants in the ion trap except that a small peak after Ang I + NO2 in Fig. 1(a)
corresponds to the copper coordinated Ang I (m/z = 453.3 Th, z = 3).
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the aﬃnity of this amino acid residue to proton may be
changed that influences the generation of triple protonated
Ang I + O. According to the calibration, the intensities
of nitrated, oxidized and unmodified Ang I on the mass
spectra can be used to calculate the amount ratio among the
three peptides as: INO2AngI/(INO2AngI + IAngI + 8IOAngI) for the
ratio of nitrated Ang I (NO2AngI) among the three peptides,
8IOAngI/(INO2AngI + IAngI + 8IOAngI) for oxidized Ang I (OAngI) and
IAngI/(INO2AngI + IAngI + 8IOAngI) for Ang I, where I is the peak
intensity on the mass spectra of the corresponding sample.
Quantitative analysis of nitration and oxidation of Ang I was
then performed.
The kinetic study was made by incubating Ang I (0.25 mM)
with copper(II) (0.025 mM), nitrite (1 mM) and ascorbic acid
(1 mM) in NH4HCO3 buﬀer (pH = 6) at 37 1C under aerobic
conditions and persistent shaking (500 rpm). We found that the
oxidation was a rather fast reaction, reaching equilibrium of
58.5% Ang I + O ratio in 30 min (ESI-2†). In contrast, the
nitration was very slow approaching equilibrium only after
55 hours of reaction, Fig. 3(a).
The influence of reactant concentrations on the nitration
and oxidation of Ang I was also studied by incubating the
peptide with various amounts of copper(II), nitrite and ascorbic
acid in NH4HCO3 buﬀer (pH = 6) at 37 1C or 25 1C under aerobic
conditions and persistent shaking (500 rpm). The reaction time
was fixed as 18 hours for all experiments. Similar nitration and
oxidation on the peptide were observed at both 37 1C and 25 1C,
whereas the reaction at higher temperature was more eﬃcient,
Fig. 3.
As shown in Fig. 3(b), both nitration and oxidation increased
with the ascorbic acid concentration. This can be easily
explained as more hydroxyl radicals were produced when more
ascorbic acid was added in the reaction system. However,
the oxidation was much more stronger and suppressed the
nitration. Even at very high concentrations of ascorbic acid,
only a small fraction of Ang I was nitrated. Keeping constant
the concentrations of copper(II) (0.025 mM) and ascorbic acid
(1 mM), the nitration increased while the oxidation decreased
with the nitrite concentration, Fig. 3(c), indicating that nitrite
acts as a hydroxyl radical scavenger to prevent the histidine
oxidation by OH and to produce the nitrogen dioxide radical
promoting tyrosine nitration. Indeed, the oxidation was very
strong when the concentration of nitrite was low, where most
Ang I was oxidized, Fig. 3(c). The role of nitrite as a hydroxyl
radical scavenger was also demonstrated by fluorometric assay
in a previous study.20
A phenomenon of interest is that nitration increased while
oxidation decreased strongly with the copper(II) concentration,
Fig. 3(d). According to our previous studies,20 copper(II) can be
coordinated by Ang I and the binding happens close to the
tyrosine residue of Ang I. The same binding site between Ang I
and copper(II) was also reported by Kim et al.35 In Fig. 1(a), the
copper coordinated Ang I is observed as a small peak after the
nitrated Ang I ((Ang I + NO2)
3+). When the copper(II) is in excess,
free copper(II) ions largely exist together with Ang I coordinated
copper(II) ions; while at low copper(II) concentration, most
cupric ions are coordinated by Ang I. Therefore, the results in
Fig. 3(d) suggest that a large amount of free copper(II) promotes
nitration of Ang I and blocks the oxidation route, while Ang I
coordinated copper(II) catalyzes preferably oxidation of Ang I.
Kawakishi et al. also reported that catalytic amounts of
copper(II) ion together with ascorbate can induce oxidation on
histidine residues of angiotensin I.36
To illustrate the role of oxygen, the same Ang I nitration
as Fig. 1(a) was performed but under anaerobic conditions.
Fig. 2 Tandem mass spectra of (a) nitrated Ang I, (b) oxidized Ang I and (c)
nitrated Ab16. The selected parent ion is at (a) m/z = 447.9 Th  1.0 Th, or
(b) m/z = 438.3 Th  1.0 Th, or (c) m/z = 667.7 Th  1.0 Th. The CID was
performed with 20–30 of instrumental collision energy. *: (a and c) nitrated
fragments and (b) oxidized fragments. The observed fragments are labeled on
the spectra and summarized as insets in the figure.
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As shown in Fig. 4, only unmodified Ang I and copper coordi-
nated Ang I were observed after 18 hours of reaction. The other
peaks on the spectrum are attributed to contaminants of the
synthesized Ang I and background contaminants in the ion
trap. These results supported the mechanism that ROS is
generated by reducing oxygen in the presence of ascorbic acid
and copper(II) to induce tyrosine nitration.
Based on the results in Fig. 3, Fig. 4 and previous mecha-
nism studies,20,32 a mechanism for the tyrosine nitration in the
presence of copper(II), ascorbic acid and nitrite is summarized
in Scheme 1. The reduction of copper(II) to copper(I) by ascorbic
acid is a key process in the generation of H2O2 and OH
radicals, where the latter can induce fast oxidation of histidine
or slow nitration of tyrosine in the presence of nitrite. During
the whole procedure copper(II) works as a catalyst, while the
overall reaction can be viewed as oxidation of ascorbic acid,
histidine and tyrosine by dissolved oxygen.
Fig. 3 (a) Ang I nitration in 1 mM NH4HCO3 (pH = 6) induced by ascorbic acid (1 mM), NO2
 (1 mM) and CuCl2 (0.025 mM) at 37 1C with various reaction times under
persistent shaking. Ang I (0.25 mM) nitration and oxidation at 25 1C or 37 1C in 1 mM NH4HCO3 induced by diﬀerent concentrations of (b) ascorbic acid, (c) nitrite and
(d) copper(II) after 18 hours of reaction under persistent shaking. b: CuCl2 = 0.025mM, NO2
 = 1mM; c: CuCl2 = 0.025mM, ascorbic acid = 1 mM; d: ascorbic acid = 1 mM,
NO2
 = 1 mM. The left y-axis shows the Ang I oxidation while the right y-axis shows the Ang I nitration. Note the diﬀerences in diﬀerent y-axis ranges. The error bars show
the standard deviations. Three experiments were conducted to obtain the standard deviations.
Fig. 4 Mass spectrum of reaction products by incubating angiotensin I (Ang I,
0.25 mM) with CuCl2 (1 mM), ascorbic acid (AA, 1 mM) and NaNO2 (1 mM) in
1 mM NH4HCO3 (pH = 6) for 18 hours at 37 1C and under persistent shaking. The
reaction was performed under the protection of nitrogen without oxygen. The
products were diluted 10 times in the ESI buﬀer and infused at a flow rate of
10 ml min1 into ESI-MS at an ionization voltage of 3.7 kV.
Scheme 1 Proposed mechanism for tyrosine nitration in the presence of nitrite,
ascorbic acid and copper(II). AA: ascorbic acid; DA: dehydroascorbic acid; His:
histidine; Tyr: tyrosine; O-His: oxidized histidine; NO2-Tyr: nitrated tyrosine. The
Cu2+ can be free cupric ions or coordinated cupric ions.
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Tyrosine nitration catalyzed by coordinated copper(II) and
under varied buﬀer conditions
During the copper(II) catalyzed tyrosine nitration on angiotensin I,
both free copper(II) and coordinated copper(II) may involve in the
reactionmechanism because of the aﬃnity between copper(II) and
Ang I. Considering the fact that the in vivo free copper concen-
tration is rather low, the performance of peptide coordinated
copper(II) in tyrosine nitration is of more interest when consider-
ing physiological conditions. b-Amyloid peptides were reported to
coordinate strongly the cupric ions.28–31 In Fig. 1, the nitration on
Ab16 has already been observed. Considering that the concen-
tration of Ab16 was much larger than copper(II), Ab16 coordinated
copper(II) catalyzed the tyrosine nitration in Fig. 1(b).
Over years, conflicting reports have been published on the
role of b-amyloid peptides in OH radical generation from
copper(II), oxygen and ascorbic acid: both antioxidant and
pro-oxidant properties have been proposed.22,23 Some reports
even suggested that b-amyloid peptides could reduce copper(II)
to copper(I) without the presence of ascorbic acid to initialize
the generation of H2O2.
37 Herein, Ab16 coordinated copper(II)
was incubated with Ang I, nitrite and ascorbic acid at pH 6.0,
37 1C, under aerobic conditions and persistent shaking (500 rpm)
for 18 hours. Besides the observation of nitrated and oxidized
Ab16 peptides, much more eﬃcient nitration on Ang I was
obtained than the copper(II) catalyzed Ang I nitration, Fig. 5.
The results show that copper(II) coordinated by peptides at a
concentration as low as 25 mM, which is actually close to the
physiological concentration of cupric ions,25 can catalyze eﬃ-
ciently oxidation or nitration of peptides. However, it is hard to
suggest that Ab16 acts as an antioxidant or a pro-oxidant since
less eﬃcient oxidation was observed meanwhile.
The results in Fig. 1 and 3 were obtained under weak acidic
conditions (pH 6.0). Influence of proton concentration on the
peptide oxidation and nitration was further studied. The reac-
tion was performed in NH4HCO3 buﬀer at various concentra-
tions. As shown in Fig. 5, nitration happened under the weak
acidic conditions (pH 6.0, 6.5) but not neutral or weak basic
conditions. The pH conditions for many human tissues are
around neutral, e.g. 7.4 for blood and brain. However, the local
pH can be mildly acidic when there is physiological acidosis
that often comes along with diseases, such as tumor and
Alzheimer’s disease.38,39 The altered neuron H+ homeostasis
was observed in common with the appearance of amyloid
deposits.39 It was reported that the Alzheimer’s disease is
complicated by cerebral acidosis of pH 6.6.40 Indeed, there
are studies on the pH influence of Ab peptide aggregation
induced by copper(II) showing that the aggregation emerged
under weak acidic conditions.39,41
Conclusion
In conclusion, we have demonstrated that tyrosine nitration can
be induced by ascorbic acid, nitrite and copper(II) or peptide
coordinated copper(II) under weak acidic and aerobic conditions
via an in vitro protocol. The phenomenon is important for several
reasons: (i) the concentration of peptide coordinated copper(II)
as low as 25 mM that is close to physiological concentration can
already catalyze tyrosine nitration; (ii) nitration was suggested to
be important for many diseases; (iii) accumulation of copper(II)
was found in Alzheimer’s disease. Our finding may establish a
potential connection between tyrosine nitration and copper(II)
toxicity for neurodegenerative diseases.
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